Diligence memo · auto-generated · as of July 2, 2026
FCA Health Innovations II QP, LP
FCA Health Innovations II QP, LP looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
FCA Health Innovations II QP, LP operates in Healthtech, based in Brentwood.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
FCA Health Innovations II QP, LP has raised $55M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $55M on 2020-11-03.
Most recent recorded round closed around 2020-11-03.
Valuation (modeled)modeled
Provath models FCA Health Innovations II QP, LP at approximately $1.3B (range $200M–$3.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.18× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era. Within the normal band (118% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 5.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 92% of Healthtech peers (2138 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: Virta Health Corp., Fresenius Medical Care Voorhees, LLC, Clear Health Pass Holdings LLC, Zealth, Inc., Jawbone Health Hub, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.